Lars Johansson

I hold a Master’s in Business Administration from the Stockholm School of Economics and have built a career as an international consultant. Specializing in mergers and acquisitions, I have advised major corporations on strategic growth. My global perspective and strategic insights are key to my contributions at Green Culture, where I offer a nuanced view of the cannabis industry. In my free time, I pursue my passion for journalism, spreading my economic knowledge and providing readers with in-depth analysis and thoughtful commentary on global cannabis trends.

Groundbreaking Cannabis Trial Shows Migraine Relief Superior to Placebo

New Trial Reveals Cannabis Effectiveness for Migraine Relief A significant medical breakthrough is emerging. The first placebo-controlled trial has found cannabis effective for migraines. This news offers new hope to millions. The study was published in Headache: The Journal of Head and Face Pain. Researchers conducted a rigorous investigation. It involved vaporized cannabis. The results…

Read More

Abstrax Unveils 2026 Cannabis Trends: Flavor, Function, and Product Innovation Guide for Brands

Abstrax Unveils 2026 Cannabis Trends Guide for Product Innovation Abstrax, a leader in terpene science and flavor innovation, has released its 2026 Cannabis Flavor & Application Trends Guide. This new resource aims to help brands innovate. It guides product launches. It also helps prioritize flavors. Building successful product portfolios is a key goal. The guide…

Read More

Korean Rapper D.Ark Cleared: Negative Drug Tests End Marijuana Allegations

Korean rapper D.Ark has officially cleared his name. He faced serious marijuana allegations. These claims involved both use and distribution. However, all investigations have now concluded. Furthermore, all tests related to these claims came back negative. D.Ark shared this news on Instagram. The post was made on January 7, 2026. He asserted his complete innocence….

Read More

Cannabis Scene 2026: Terpene Trends, New Strains, and Market Shifts Define the Year

The cannabis landscape is rapidly evolving. January 2026 sees a significant shift. Consumers now prioritize complex terpene profiles. Unique flavor experiences are more important than pure THC potency. This trend drives innovation in breeding and cultivation. Terpene-Driven Experiences Take Center Stage Terpenes are no longer a niche focus. They dictate flavor, aroma, and effects. This…

Read More

California Cannabis Market Sees Major Consolidation Amidst Renewed Investor Optimism

California’s cannabis industry is experiencing a significant shift. Several major deals signal growing optimism for the new year. Vireo Growth Inc. acquired the cannabis delivery company Eaze. This deal was valued at $47 million. It was a stock-based transaction. Stiiizy also expanded its reach. The company purchased 12 former Gold Flora dispensaries. This acquisition cost…

Read More

California Cannabis Market Heats Up: $47M Eaze Deal and Consolidation Spark New Year Optimism

California’s cannabis industry shows new life. The market faced tough times recently. Now, major deals signal a fresh start. Optimism is trending for the new year. Several significant events are driving this shift. These news items paint a promising picture. Vireo Growth Acquires Eaze Vireo Growth Inc. made a big move. It acquired cannabis delivery…

Read More

Carnegie Hill Cannabis Co. Opens Doors Dec. 29th, Bringing Premium Products and Elevated Experience to NYC’s Upper East Side

Carnegie Hill Cannabis Co. officially opens on December 29, 2025. It is a new adult-use dispensary. The location is 1720 Second Avenue. This is on Manhattan’s Upper East Side. The state licenses this cannabis business. The New York State Office of Cannabis Management granted its license. This opening is a significant event. It marks another…

Read More

Trump Considers Executive Order: Cannabis Moves Closer to Schedule III

President Donald Trump is reportedly considering a major policy shift. He may issue an executive order soon. This order could reclassify cannabis. It would move marijuana from Schedule I to Schedule III. This potential move has sent ripples through the industry. It could change tax rules significantly. It might also encourage more investment. Understanding Drug…

Read More